Trials / Conditions / Acute Hepatic Porphyria
Acute Hepatic Porphyria
7 registered clinical trials studyying Acute Hepatic Porphyria — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome NCT05344599 | Vanderbilt University Medical Center | — |
| Completed | Prevalence of Acute Hepatic Porphyria NCT04923516 | Association pour la Recherche en Medecine Interne | — |
| Recruiting | ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP) NCT04883905 | Alnylam Pharmaceuticals | — |
| Terminated | INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical NCT03547297 | Alnylam Pharmaceuticals | — |
| Completed | ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Po NCT03338816 | Alnylam Pharmaceuticals | Phase 3 |
| Completed | EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP) NCT02240784 | Alnylam Pharmaceuticals | — |
| Approved For Marketing | Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria NCT04056481 | Alnylam Pharmaceuticals | — |